Spark Investment Management LLC Intercept Pharmaceuticals, Inc. Transaction History

Spark Investment Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$46.7 - $92.04 $845,270 - $1.67 Million	-18,100 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$48.35 - $118.68 $304,605 - $747,684	-6,300 Reduced 25.82%	18,100 $1.14 Million
Q4 2019 Feb 11, 2020	SELL	$57.36 - $124.1 $2.6 Million - $5.62 Million	-45,300 Reduced 64.99%	24,400 $3.02 Million
Q2 2019 Aug 12, 2019	SELL	$77.77 - $120.68 $1.95 Million - $3.03 Million	-25,100 Reduced 26.48%	69,700 $5.55 Million
Q1 2019 May 07, 2019	BUY	$91.83 - $120.68 $8.71 Million - $11.4 Million	94,800 New	94,800 $10.6 Million
Q3 2018 Nov 13, 2018	SELL	$88.49 - $127.55 $5.57 Million - $8.02 Million	-62,900 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$60.0 - $85.67 $4.42 Million - $6.31 Million	-73,600 Reduced 53.92%	62,900 $5.28 Million
Q1 2018 May 10, 2018	SELL	$52.72 - $67.25 $2.35 Million - $3 Million	-44,610 Reduced 24.63%	136,500 $8.4 Million
Q4 2017 Feb 12, 2018	BUY	$58.2 - $72.76 $3.21 Million - $4.02 Million	55,210 Added 43.85%	181,110 $10.6 Million
Q3 2017 Nov 13, 2017	BUY	$57.01 - $118.75 $7.18 Million - $15 Million	125,900	125,900 $7.31 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.